Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
A Eustachian tube balloon dilation system is a prescription medical device: a flexible catheter with an inflatable balloon at its tip, regulated by FDA as Class II under 21 CFR 874.4180 (product code PNZ). This page describes what the device is, what FDA requires of its makers, and how the cleared systems differ on paper. It is written for clinic staff, buyers and students who need a regulatory and specification reference.
This page describes products and general use; it is not medical advice.
Who uses it: the device is a prescription device, and FDA files it under the Ear, Nose, Throat medical specialty. Its labeling, not this page, defines who may use it and on which patients.
What it is
The federal regulation defines it in one sentence: “A Eustachian tube balloon dilation system is a prescription device that includes a flexible catheter attached to an inflatable balloon. The system is intended for use in dilating the cartilaginous portion of the Eustachian tube for treating persistent Eustachian tube dysfunction” (21 CFR 874.4180(a), checked 2026-10-30).
In FDA’s classification database the product code PNZ is named “Eustachian Tube Balloon Dilation Device”. The record lists it as Class II, not an implant, and not life-sustaining or life-supporting (openFDA device classification, data last updated 2026-10-19, checked 2026-10-30).
How it is built
The regulation names two defining parts, a flexible catheter and an inflatable balloon. The FDA 510(k) summary for the Audion ET dilation system (K220027, checked 2026-10-30) gives one concrete example: a curved, non-malleable shaft with a 1.26 mm outer diameter, a balloon fixed at the distal end, and an inflation device (syringe and extension line) and an optional inflation lock. That system’s inflation device delivers 12 atm, and at 12 atm the balloon is 6 mm in diameter with a 20 mm body length.
These figures belong to that one system. Other cleared systems have their own parameters, which their labeling must state (see the next sections).
Regulatory class and what makers must show
The device is Class II (special controls). Under 21 CFR 874.4180(b), special controls include:
- non-clinical testing of catheter-joint tensile and flexural strength, balloon durability (including fatigue and burst pressure), inflation and deflation time and pressure, leak testing, and safety features such as catheter geometry and distal tip insertion limits;
- simulated-use testing in a clinically relevant model, validating that the design features limit access to only the cartilaginous portion of the Eustachian tube;
- biocompatibility of patient-contacting components, sterility, and shelf life (sterility, package integrity and function);
- training that includes simulated use on cadavers; and
- labeling with detailed instructions for use, a summary of technical parameters “including maximum allowed inflation pressure, allowable catheter geometries, and available balloon sizes”, and a shelf life.
For a buyer or student, the practical reading is that maximum inflation pressure, catheter geometry and balloon sizes are items the manufacturer’s labeling is required to list, so those are the figures to look for in a specific product’s instructions for use. The classification record links one De Novo request (DEN150056) and several 510(k) clearances. See the CASRAI entry on FDA De Novo classification and the overview of the Medical Device Amendments of 1976, which created the device classes. For how clearances like those below are reached, see the guide to FDA 510(k) premarket notification and the explanation of a predicate device and substantial equivalence.
Types and variants
Several systems carry the PNZ product code. The table lists the five most recent 510(k) records in openFDA (checked 2026-10-30); all five show the decision “Substantially Equivalent” and a Traditional 510(k) type.
| System | Applicant | 510(k) | Decision date |
|---|---|---|---|
| AERA Eustachian Tube Balloon Dilation System | Acclarent | K253612 | 2026-02-19 |
| AERA Eustachian Tube Dilation System | Acclarent | K230742 | 2023-12-13 |
| TubaVent Balloon Dilatation System | Spiggle and Theis Medizintechnik GmbH | K223542 | 2023-08-03 |
| VenSure family (VenSure, Light, Nav, ET) | Fiagon GmbH | K230065 | 2023-05-26 |
| Audion ET dilation system | Entellus Medical | K220027 | 2022-04-12 |
The full PNZ record also links K163509, K171761 and K210841.
Sizes and specifications that matter
| Specification | Value stated | System and source |
|---|---|---|
| Shaft outer diameter | 1.26 mm, curved, non-malleable | Audion ET, K220027 summary |
| Inflation pressure | 12 atm | Audion ET, K220027 summary |
| Balloon diameter at 12 atm | 6 mm | Audion ET, K220027 summary |
| Balloon body length | 20 mm | Audion ET, K220027 summary |
| Balloon catheter size (inflated diameter x length) | 6 x 16 mm, flexible | AERA, K230742 summary |
| Supply condition | Provided sterile, single patient use | K220027 and K230742 summaries |
How to choose
The sources describe criteria that are fixed by labeling, not by a buying rule:
- Labeled parameters. Per 21 CFR 874.4180, the labeling lists maximum inflation pressure, allowable catheter geometries and balloon sizes, so compare those figures between instructions for use.
- Indications and contraindications. Each system’s cleared indications are stated in its own 510(k) summary and instructions for use; the K220027 and K230742 summaries differ in wording, so read the one for the specific product.
- Supply condition. Both summaries state the devices are provided sterile for single-patient use. Symbols on the pack are explained in the guide to medical device labeling symbols.
Safe use and handling basics
Both 510(k) summaries cited here state that the devices are provided sterile and for single-patient use. The regulation requires training that includes simulated use on cadavers, and instructions for use that the manufacturer must supply. Use is governed by the product’s instructions for use and a clinician’s judgment, and this page does not give procedural instructions. Device problems in the United States are reported under Medical Device Reporting.
Common mistakes
- Applying one system’s numbers to another. The 12 atm, 6 mm and 20 mm figures come from one 510(k) summary; each system has its own labeled parameters.
- Treating one system’s labeling as universal. The two summaries state different indication language; check the labeling of the specific product.
- Reading a database listing as a product record. The openFDA listing gives names, dates and numbers; the 510(k) summary and the instructions for use hold the product details.
FAQ
Is an Eustachian tube balloon dilation device a prescription device?
Yes. 21 CFR 874.4180(a) identifies it as “a prescription device” (checked 2026-10-30).
What FDA class is it?
Class II with special controls, regulation number 874.4180, product code PNZ (openFDA classification, checked 2026-10-30).
What is in the system?
By regulation, a flexible catheter attached to an inflatable balloon. The K220027 summary also lists an inflation device and an optional inflation lock as part of the Audion system.
Is it single use?
The K220027 and K230742 summaries both state the devices are provided sterile and for single-patient use.
Sources
- 21 CFR 874.4180, Eustachian tube balloon dilation system: law.cornell.edu/cfr/text/21/874.4180 (checked 2026-10-30).
- openFDA device classification, product code PNZ: api.fda.gov device classification (checked 2026-10-30).
- openFDA 510(k) records, product code PNZ: api.fda.gov 510(k) (checked 2026-10-30).
- FDA 510(k) summary K220027: accessdata.fda.gov K220027 (checked 2026-10-30).
- FDA 510(k) summary K230742: accessdata.fda.gov K230742 (checked 2026-10-30).







